<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:xhtml="http://www.w3.org/1999/xhtml">
  <url>
    <loc>https://www.dermbiont.com/home</loc>
    <changefreq>daily</changefreq>
    <priority>1.0</priority>
    <lastmod>2025-09-23</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5be33300f93fd46b40da5761/1550008929697-DRPUC4UBVA8LJ3WE1P2L/bg_01.jpg</image:loc>
      <image:title>Homepage</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.dermbiont.com/in-the-news</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2024-08-15</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5be33300f93fd46b40da5761/1654491915181-RBM3R48S35JTFKRHSRYK/bg_02.jpg</image:loc>
      <image:title>In the News</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.dermbiont.com/in-the-news/dermbiont-announces-treatment-of-labcc-and-prevention-of-bcc-in-gorlin-syndrome-patients-as-new-lead-indications-for-sm-020-following-positive-initial-phase-2a-data</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2024-08-15</lastmod>
  </url>
  <url>
    <loc>https://www.dermbiont.com/in-the-news/2024/2/22/dermbiont-announces-2024-development-pipeline-update-for-its-first-in-class-targeted-topical-therapeutics-for-seborrheic-keratoses-basal-cell-carcinomas-and-melasma</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2024-02-22</lastmod>
  </url>
  <url>
    <loc>https://www.dermbiont.com/in-the-news/2023/10/24/dermbiont-announces-first-close-of-352-million-in-a-series-b-financing-to-advance-first-in-class-targeted-topical-dermatological-therapeutics</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2023-10-24</lastmod>
  </url>
  <url>
    <loc>https://www.dermbiont.com/in-the-news/2023/5/30/dermbiont-announces-positive-data-from-a-phase-2-trial-treating-solar-lentigos-and-normalizing-pigmentation-of-the-skin-with-08-sm-030-topical-gel</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2023-05-30</lastmod>
  </url>
  <url>
    <loc>https://www.dermbiont.com/in-the-news/2023/3/22/dermbiont-presents-positive-phase-2-trial-data-treating-seborrheic-keratosis-with-sm-020-topical-gel-at-american-academy-of-dermatology-annual-meeting</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2023-03-22</lastmod>
  </url>
  <url>
    <loc>https://www.dermbiont.com/in-the-news/2022/06/23/dermbiont-announces-positive-phase-2-clinical-trial-data-treating-seborrheic-keratosis-with-sm-020-the-first-and-only-targeted-topical-treatment-for-these-common-benign-tumors</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2022-09-07</lastmod>
  </url>
  <url>
    <loc>https://www.dermbiont.com/in-the-news/2021/12/21/dermbiont-raises-28-million-and-acquires-chromaderm-to-expand-targeted-topical-therapeutics-in-development</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2022-09-07</lastmod>
  </url>
  <url>
    <loc>https://www.dermbiont.com/in-the-news/2020/10/21/dermbiont-announces-acquisition-of-seylanmed-to-expand-its-portfolio-of-targeted-topical-therapeutics-treating-skin-diseases-at-their-root-cause</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2022-09-07</lastmod>
  </url>
  <url>
    <loc>https://www.dermbiont.com/in-the-news/category/News</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.dermbiont.com/in-the-news/category/Press+Release</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.dermbiont.com/in-the-news/category/Press+Releases</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.dermbiont.com/in-the-news/category/Blog</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.dermbiont.com/press-releases</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2019-02-12</lastmod>
  </url>
  <url>
    <loc>https://www.dermbiont.com/in-the-news-new</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2019-02-12</lastmod>
  </url>
  <url>
    <loc>https://www.dermbiont.com/blog</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2019-02-12</lastmod>
  </url>
  <url>
    <loc>https://www.dermbiont.com/dermatology-platform</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2022-06-07</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5be33300f93fd46b40da5761/1549272848418-GI3CS0PUBP0V38ARB10M/bg_06.jpg</image:loc>
      <image:title>Dermatology Platform</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.dermbiont.com/small-molecules</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2022-06-07</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5be33300f93fd46b40da5761/1544737522553-HCRDK5B1C7DCE5BZW847/joel-filipe-196735-unsplash.jpg</image:loc>
      <image:title>Small Molecules</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.dermbiont.com/careers</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-09-23</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5be33300f93fd46b40da5761/1549272946128-NMA7XV3MMBRDSVKCQ6FZ/bg_03.jpg</image:loc>
      <image:title>Careers</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5be33300f93fd46b40da5761/1547024151572-UI1HEU3YUR9FG0Y6FWLT/bg_04.jpg</image:loc>
      <image:title>Careers</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.dermbiont.com/overview</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-09-23</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5be33300f93fd46b40da5761/1547024055631-SA5KSI9EYEMIIXMA9WFF/bg_03.jpg</image:loc>
      <image:title>Overview</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.dermbiont.com/contact-us</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-09-23</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5be33300f93fd46b40da5761/1547024246786-LWYOVZQ1PCQRN68PLS9R/bg_05.jpg</image:loc>
      <image:title>Contact Us</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.dermbiont.com/pipeline</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-09-23</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5be33300f93fd46b40da5761/611fd373-06ce-4629-8eea-953c339af86f/1.png</image:loc>
      <image:title>Pipeline - Make it stand out</image:title>
      <image:caption>Whatever it is, the way you tell your story online can make all the difference.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5be33300f93fd46b40da5761/accbc810-4d7a-424b-ab05-6e55d6c727cb/01.png</image:loc>
      <image:title>Pipeline</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5be33300f93fd46b40da5761/1544732958809-3XGIV54ME563JD5TNAYZ/joel-filipe-199037-unsplash.jpg</image:loc>
      <image:title>Pipeline</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.dermbiont.com/karl-beutner</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2021-06-25</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5be33300f93fd46b40da5761/1549232921904-P3TWCAN89W1J2L587J2C/Karl+Beutner.jpg</image:loc>
      <image:title>Karl Beutner</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.dermbiont.com/max-n-dawson</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2019-09-25</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5be33300f93fd46b40da5761/1549232990181-0KN0M9II13T6EADJYC11/Max+N.+Dawson.jpg</image:loc>
      <image:title>Max N. Dawson</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.dermbiont.com/xuecheng-zhang-phd</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2021-09-01</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5be33300f93fd46b40da5761/1549233097516-LSAD0P653K6X8B0L2FLT/Xuecheng+Zhang%2C+PhD.jpg</image:loc>
      <image:title>Xuecheng Zhang, PhD</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.dermbiont.com/claudia-koontz</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2019-02-07</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5be33300f93fd46b40da5761/1549233152297-D5KARS8GAXF1E4DS4A42/Claudia+Koontz.jpg</image:loc>
      <image:title>Claudia Koontz</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.dermbiont.com/tina-landess</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2019-02-07</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5be33300f93fd46b40da5761/1549233072123-RK7M4LCENDDPIZ1TF3FR/Tina+Landess.jpg</image:loc>
      <image:title>Tina Landess</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.dermbiont.com/bhanu-prakash-sakhamuri</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2019-02-07</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5be33300f93fd46b40da5761/1549233238030-45CED0XVCSLGWQI5AB44/Bhanu+Prakash+Sakhamuri.jpg</image:loc>
      <image:title>Bhanu Prakash Sakhamuri</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.dermbiont.com/robert-m-brucker</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2022-06-15</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5be33300f93fd46b40da5761/1581569280421-31MDRLMGF3ESBO2C8BLA/Robert+M.+Brucker-02.jpg</image:loc>
      <image:title>Robert M. Brucker</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.dermbiont.com/shilpa-goel-md</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2019-02-07</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5be33300f93fd46b40da5761/1549233121200-BJJ1CITZTOU8MFDR355C/Radhika%2C+PhD.jpg</image:loc>
      <image:title>Shilpa Goel, MD</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.dermbiont.com/taylor-chang</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2019-02-07</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5be33300f93fd46b40da5761/1549233214792-D3MBX3AIEOU7VR10H26G/Taylor+Chang.jpg</image:loc>
      <image:title>Taylor Chang</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.dermbiont.com/sanjay-jain-phd</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2020-03-20</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5be33300f93fd46b40da5761/1549233047862-KHCAE51JNJ9ZXJAP6AXJ/Sanjay+Jain%2C+PhD.jpg</image:loc>
      <image:title>Sanjay Jain, PhD</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.dermbiont.com/nick-eliovits</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2024-03-07</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5be33300f93fd46b40da5761/1549233017886-YVL2W3VSNEUREEOYSPA8/Nick+Eliovits.jpg</image:loc>
      <image:title>Nick Eliovits</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.dermbiont.com/ida-lister-phd</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2019-02-07</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5be33300f93fd46b40da5761/1549233183825-9JXCERH2XU280L1FWT5T/Ida+Lister%2C+PhD.jpg</image:loc>
      <image:title>Ida Lister, PhD</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.dermbiont.com/leadership</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-09-23</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5be33300f93fd46b40da5761/1624899759175-TZ34E57UFG4KZDMQOPKN/Emma_Taylor_Headshot.jpg</image:loc>
      <image:title>Leadership - Emma Taylor, MD</image:title>
      <image:caption>Emma Taylor, MD CHIEF MEDICAL OFFICER</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5be33300f93fd46b40da5761/1549232488617-ZRCERLFH6ZB8O2SX334A/Karl+Beutner.jpg</image:loc>
      <image:title>Leadership - Karl Beutner, MD, PhD</image:title>
      <image:caption>Chief Executive Officer</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5be33300f93fd46b40da5761/1548978704871-9JTJNAKGMQTWG0N4RZ7S/Nick+Eliovits.jpg</image:loc>
      <image:title>Leadership - Nichola (Nick) Eliovits</image:title>
      <image:caption>CHIEF Financial OFFICER</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5be33300f93fd46b40da5761/1548978690082-R19XDF4GWSPTD26GRL0F/Max+N.+Dawson.jpg</image:loc>
      <image:title>Leadership - Max N. Dawson</image:title>
      <image:caption>Chief OPERATING Officer</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5be33300f93fd46b40da5761/1654491958205-5EYRV5RQQ5NTPEDF1U4B/bg_02.jpg</image:loc>
      <image:title>Leadership</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.dermbiont.com/deryck-wade</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2019-03-27</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5be33300f93fd46b40da5761/1553668010573-65DG0WAZWBSUP9HNRX0L/Max+N.+Dawson.jpg</image:loc>
      <image:title>Deryck Wade</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.dermbiont.com/emma-taylor-md</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-09-23</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5be33300f93fd46b40da5761/1624900246757-9Q7541FNMND5XGF595J7/Emma_Taylor_Headshot.jpg</image:loc>
      <image:title>Emma Taylor, MD</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.dermbiont.com/platform</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-09-23</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5be33300f93fd46b40da5761/1549272848418-GI3CS0PUBP0V38ARB10M/bg_06.jpg</image:loc>
      <image:title>Platform</image:title>
    </image:image>
  </url>
</urlset>

